Bavarian Nordic Updates FY24 Outlook

(RTTNews) - Bavarian Nordic A/S (BVNRY.PK), Thursday announced an updated guidance for the fiscal year 2024, primarily due to the bulk Mpox vaccine orders secured by the company as well as improved performance in Travel Health.

The company now expects revenue of DKK 5,400 million to DKK 5,800 million and EBITDA of DKK 1,450 million to DKK 1,700 million for the full year.

Currently, Bavarian Nordic's stock is trading at $11.77, down 1.25 percent on the OTC Markets.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.